Edwards gains CE mark approval for new tricuspid valve replacement device

[ad_1] Edwards has been evaluating the safety and effectiveness of the Evoque system for quite some time. In November 2022, the company shared one-year data from the TRISCEND study that…

What new tricuspid valve data tell us about the future of patient care

[ad_1] The biggest tricuspid study presented at ESC Congress 2023 was TRI-SCORE, which evaluated a tricuspid risk scoring system to determine the best time to intervene on patients. It also…

TRILUMINATE trial may pave the way for FDA clearance for tricuspid valve clip device

[ad_1] Paul Sorajja, MD, director, Center for Valve and Structural Heart Disease, Minneapolis Heart Institute, Abbott Northwestern Hospital, was the principal investigator for the late-breaking TRILUMINATE pivotal trial at the…